Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators

David Workman, Andrew Tsatsanis, Frank Lewis, John Boyle, Maryam Mousadoust, Nishani Hettiarachchi, Michael Hunter, Chris Peers, David Tetard, James Duce

Research output: Contribution to journalArticlepeer-review

35 Citations (Scopus)
34 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science